Kakkassery, V <br/><br/>
[Anti-VEGF inhibitors and their role in the treatment of diabetic macular oedema].  [electronic resource] 

 -  Klinische Monatsblatter fur Augenheilkunde  Sep 2010 
 - 701-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1439-3999 
<br/><br/><label>Standard No.: </label>10.1055/s-0029-1245718  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Aptamers, Nucleotide--administration & dosage<br/>Bevacizumab<br/>Blood-Retinal Barrier--drug effects<br/>Capillary Permeability--drug effects<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Diabetic Retinopathy--classification<br/>Fluorescein Angiography<br/>Humans<br/>Intravitreal Injections<br/>Laser Coagulation--adverse effects<br/>Macular Edema--classification<br/>Middle Aged<br/>Off-Label Use<br/>Ranibizumab<br/>Receptors, Vascular Endothelial Growth Factor<br/>Recombinant Fusion Proteins--administration & dosage<br/>Retinoscopy<br/>Triamcinolone--administration & dosage<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors